Brain and Nerve Centre Lectures

Wednesday 8 May 2019
Location: azM Greepzaal (Room: 4.E2.020)
09:00 hrs. | Lecture: Dr. Robert W. Mays, Head of Neurosciences and Vice President of Regenerative Medicine at Athersys, Inc. | Title: Conserved Mechanisms Underlying the Benefit of MultiStem Cell Therapy, for Treatment of Acute Injuries of the Central Nervous System
10:00 hrs. | Reint Jellema | Title: Stem cells for neonatal brain injury
10:30 hrs | Jeroen Vermeulen | Title: Neonatal neuroimaging

Short Bio

Dr. Mays is the Head of Neurosciences and Vice President of Regenerative Medicine at Athersys, Inc. He is focused on the company’s novel adult human stem cell product, MultiStem®, and its applications in Regenerative Medicine and drug discovery, with a specific focus on injuries and diseases affecting the central nervous system. Dr. Mays was the Principal Investigator of the MASTERS (MultiStem Administration for Stroke Treatment and Enhanced Recovery Study) clinical trial assessing the safety and efficacy of MultiStem in treatment of ischemic stroke. He is also the Principal Investigator of the pivotal Phase III MASTERS-2 study, which has received RMAT, Fast Track and Special Protocol Assessment designations from the FDA. Dr. Mays is a member of the National Center for Regenerative Medicine, Center for Stem Cell and Regenerative Medicine, the American Heart Association and is an Adjunct Professor at the Case Western Reserve University School of Medicine. He has authored or co-authored >30 peer reviewed scientific papers or reviews and is the inventor of more than 10 patents relating to the use of stem cells for treating disease. Dr. Mays is on the Commercialization Committee and Co-chair of the Neuroscience Committee for the International Society for Cellular Therapy, and previously the Board of Directors for the United Cerebral Palsy Foundation of Cleveland and the scientific advisory board for the Children’s Neurobiological Solutions Network in Los Angeles. He graduated from Carnegie Mellon in 1987 with a B.S. in Cell and Developmental Biology. In 1994, he received his Ph.D. in Molecular and Cellular Physiology at Stanford University. After doing Post-doctoral research at the University of Utrecht in the Netherlands, the Weizmann Institute in Rehovot, Israel and the University of California, San Francisco, Dr. Mays co-founded Athersys Inc., which focuses on developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life.